theheart.org: Interventional Surgery news and studies. Duke and Mayo partnership.

Interventional/Surgery

PCI in Left Main Disease: Are We There Yet?

1 COMMENT - Nov 11, 2009 11:41 EST

SYNTAX and MAIN-COMPARE suggest a role for PCI in subsets of patients with left main disease; however, in current ACC/AHA guidelines this remains a class III indication. Dr. Turco chairs a roundtable with interventionalists Drs Kandzari and Park and surgeon Dr Sabik.

Interventional/Surgery

Revascularization in Patients With Diabetes

Oct 7, 2009 14:12 EDT

Since BARI, CABG has been the gold standard for patients with diabetes and multivessel disease. However, SYNTAX suggests an increasing role for PCI and BARI 2D highlights the importance of optimal medical therapy. Dr. Boden leads a multidisciplinary discussion with Drs. Holmes and Taggart.

Interventional/Surgery

Dual Antiplatelet Therapy: Dueling Options in Real-World Practice

2 COMMENTS - Sep 30, 2009 13:31 EDT

With the recent approval of a third-generation thienopyridine, choice of agent can be added to the list of considerations in the management of ACS patients, as well as the appropriate timing and dosing of thienopyridine. Using some case vignettes, Dr. King leads a discussion with Drs. Bhatt and Steg on their clinical decision-making.

Acute Coronary Syndromes

Antiplatelet Therapy: A Brazilian Expert's Take

1 COMMENT - Jul 14, 2009 12:00 EDT

From SOLACI 2009 in Rio de Janeiro. Dr. Mahmud hears how Dr. Feres interprets the data on antiplatelet/antithrombin strategies for his practice in Brazil.

Interventional/Surgery

Transcatheter Aortic Valves: Lessons From Europe

Jun 26, 2009 00:02 EDT

Transcatheter aortic valve implantation (TAVI) has been approved in Europe since 2007, whereas these devices are just entering large-scale research trials in the United States. Dr. Popma leads a panel discussion with European interventionalist Dr. Eberhard Grube and surgeon Dr. Neil Moat on their experiences with TAVI.

Interventional/Surgery

DES and PCI: Endurance and New Frontiers

2 COMMENTS - Jun 23, 2009 00:45 EDT

Given SYNTAX, is left main stenting ready for primetime? Do the NCDR data lay to rest DES safety concerns? Recorded at EuroPCR 2009, Dr. Popma discusses the current status and future roles of PCI and DES with Drs.Gershlick and Tamburino.

Interventional/Surgery

Assessing Long-term Risks & Benefits of DES and BMS

2 COMMENTS - Apr 20, 2009 00:00 EDT

When choosing between DES and BMS or among the various DES, how much weight should be given to 1-year data vs the totality of evidence? What is the duration of stent thrombosis risk? Dr. Leon leads a panel discussion to address these issues with Drs. Kandzari and Yeung.

Interventional/Surgery

Thoracic Aneurysms: Open vs Endovascular Approaches

2 COMMENTS - Apr 20, 2009 00:00 EDT

Learn about the current status of less-invasive strategies to repair thoracic aneurysms as Dr. Mack leads a discussion with vascular surgeons, Drs. Kasirajan and Woo. Which cases are amenable to endovascular repair and which require open surgery?

Acute Coronary Syndromes

Antiplatelet Options for ACS: The Changing Landscape

Feb 12, 2009 09:00 EST

On February 3, 2009, the FDA's Cardiovascular and Renal Drugs Advisory Committee unanimously voted to recommend approval of the novel thienopyridine prasugrel for use in ACS patients undergoing PCI. Drs. Nissen, Ohman, Kandzari, Topol, and Steg each give their take on the likely implications for clinical practice and remaining issues of concern in the optimal management of patients with ACS.

	Yes
	No